GHK-CU Peptide Guide

GHK-Cu is a naturally occurring copper-binding peptide widely discussed in skin, collagen, and tissue-remodeling contexts. This page explains what it is and how clinician-supervised programs through ElliotMeds work. It is educational and not medical advice.

Last updated: July 2, 2026

What Is GHK-CU?

GHK-Cu is a naturally occurring copper-binding tripeptide — glycyl-L-histidyl-L-lysine complexed with copper. It is discussed for skin quality, collagen, hair, and tissue remodeling. Topical cosmetic use and injectable wellness use have very different risk profiles; injectable GHK-Cu is not FDA-approved for anti-aging or skin rejuvenation.

How It Works

GHK-Cu is studied for signaling related to collagen, elastin, glycosaminoglycans, fibroblast activity, antioxidant pathways, and tissue remodeling. Much of the strongest consumer use is topical/cosmetic; for injectable use, the evidence base is more limited. It is not a guaranteed outcome.

What It’s Studied For

GHK-Cu has research and reviews discussing skin remodeling, wound healing, collagen and elastin pathways, anti-inflammatory and antioxidant effects, and tissue repair — much of it topical. Injectable use has less human safety data. It is not FDA-approved for these uses.

Regulatory Status

The cosmetic-versus-drug boundary is sharp for GHK-Cu: topical cosmetic products are a different regulatory category from an injectable used with therapeutic intent. Injectable GHK-Cu is not FDA-approved, and the FDA has noted limited human data and concerns around immunogenicity and impurities for injectable GHK-Cu. Compounding availability is subject to that status.

What to Expect

Use is provider-directed only; no skin, anti-aging, or hair outcome or timeline is promised, and effects are individual and unverified for these purposes.

Preferred Starting Options / Dosing Notes

Many patients begin with a lower starting option so a licensed clinician can evaluate tolerance, medical history, goals, and safety factors before any adjustments are considered. The starting option shown below is informational and reflects available program data, not self-directed dosing instructions. Final medication, dose, frequency, and treatment plan are determined by a licensed clinician.

Safety Considerations

• Injectable human data are limited, with possible injection-site reactions, hypersensitivity, and copper-related considerations.
• Sterility and purity are concerns, and long-term effects are unknown.
• No peptide is "safe" without qualification.

Who Is Not a Candidate

A clinician reviews copper-related and liver considerations, allergies, skin goals, wound status, pregnancy status, medications, and whether topical options are more appropriate, before considering injectable GHK-Cu.

How It Compares

GHK-Cu is a copper-binding peptide distinct from GH-pathway or recovery peptides; topical formulations differ substantially in risk from injectable use. None is presented as superior, and a clinician determines what, if anything, fits.

Frequently Asked Questions

References

• Peer-reviewed dermatology/skin-remodeling literature on GHK-Cu (PubMed)
• FDA compounding-safety communications on injectable GHK-Cu